skip to content »

Pathology

Houston, Texas

Department of Pathology
Pathology
not shown on screen

Faculty

Jon A. Reed, M.D., F.C.A.P. Professor Emeritus

Jon A. Reed

Education

  1. M.D., Pennsylvania State University College of Medicine, Hershey, PA

  2. M.S., Biology, Pennsylvania State University, University Park, PA

  3. B.S., Microbiology, Pennsylvania State University, University Park, PA

Residency

  1. Anatomic Pathology: Yale-New haven Hospital, New Haven, CT

Fellowship

  1. Molecular Pathology: University of Oklahoma Health Science Center, Oklahoma City, OK

  2. Dermatopathology: New York Hospital-Cornell University Medical Center, New York, NY

Specialty

  1. Dermatopathology

Board Certification

  1. Anatomic Pathology, 11/1992

  2. Dermatopathology, 11/1993

Area of Interest

  1. Dermatopathology

  2. Melanomag

  3. melanocytic (pigmented) lesions

  4. Signal transduction pathways involved in melanocyte differentiation and in melanoma tumor progression

Current Position

  1. Professor Emeritus

Professional Positions Held

  1. Professor of Pathology and Dermatology; Director Section of Dermatopathology, Baylor College of Medicine; Director, Histology services Laboratory, 2005-Jan 2, 2009

  2. Associate Professor of Pathology and Dermatology; Director Section of Dermatopathology, Baylor College of Medicine, 1999-2005

  3. Assistant Professor of Pathology, Cornell University Medical College (The Joan and Sanford Weill College of Medicine of Cornell University), 1994-1998

Other Positions

  1. Editorial Board, American Journal of surgical Pathology

  2. Editorial Board, Journal of Cutaneous Pathology

  3. Section Editor Archives of pathology and Laboratory medicine

  4. Ad hoc reviewer for 10 additional peer reviewed scientific and medical journals

  5. Consultant Medical Staff: Harris County Hospital District / Ben Taub General Hospital

Honors and Awards

  1. Named one of America's Best Doctors: 2001-2002; 2003-2004, 2005-2006

Membership on professional organizations

  1. Fellow, College of American Pathologists

  2. Fellow, American Society of Dermatopathology

  3. Founding Member, Society for Melanoma Research

  4. United States and Canadian Academy of Pathology

  5. Harris County Medical Society

  6. Houston Society of Clinical Pathologists

  7. Association of Dermatopathology Fellowship Training Directors

  8. Society for Applied Immunohistochemistry: Board of Directors, 1995-2000

  9. Pan-American Society for Pigment Cell Research, Program Committee, 2000

  10. Invited participant 1st Workshop, Melanoma Research Foundation, 2001

  11. Program Director, 45th Annual Symposium Houston Society of Clinical Pathology, 2005

Representative Publications

  1. Reed JA, Medrano EE. Recent advances in melanoma. Frontiers in Bioscience 11: 3003 – 3013, 2006

  2. Reed JA, Lin Q, Chen D, Mian IS, Medrano EE. SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev 24: 265 – 272, 2005

  3. Bales E, Mills L, McGahren M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi J, Medrano EE. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res 65: 692 – 697, 2005

  4. Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express markers of the early neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 29: 562 – 568, 2002

  5. Trejo O, Reed JA, Prieto VG. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM, AND GAP-43: Evidence of early Schwann Cell Differentiation. J Cutan Pathol 29: 397 – 406, 2002

  6. Reed JA, Xu W, Bales E, Bandyopadhyay D, Okan N, Colmenares C, Medrano EE. Overexpression and localization of the oncogenic protein Ski in cutaneous human melanomas: consequences for TGF-ß signaling. Cancer Res 61: 8074 – 8078, 2001

  7. Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP. Loss of expression of protein kinase C ß is a common phenomenon in human malignant melanoma. Melanoma Res 11: 355 – 369, 2001

  8. Fullen D, Reed JA, Finnerty B, McNutt NS. S100A6 expression in melanocytic neoplasms. J Cutan Pathol 28: 393 - 399, 2001

  9. Reed JA, Albino AP. Update of prognostic and diagnostic markers in Cutaneous Malignant melanoma. Clinics Lab Med 20: 817 – 838, 2000

  10. Reed JA, Finnerty, B, Albino AP. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am J Pathol 155: 549 – 555, 1999